Prognostic and clinicopathological value of CDK12 mutation in prostate cancer: a meta-analysis
出版年份 2023 全文链接
标题
Prognostic and clinicopathological value of CDK12 mutation in prostate cancer: a meta-analysis
作者
关键词
-
出版物
Expert Review of Anticancer Therapy
Volume -, Issue -, Pages 1-10
出版商
Informa UK Limited
发表日期
2023-02-03
DOI
10.1080/14737140.2023.2168647
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cancer statistics, 2022
- (2022) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- BRCA2, ATM, and CDK12 defects differentially shape prostate tumor driver genomics and clinical aggression
- (2021) Evan W. Warner et al. CLINICAL CANCER RESEARCH
- Differential Treatment Outcomes in BRCA1/2 ‐, CDK12 ‐, and ATM ‐Mutated Metastatic Castration‐Resistant Prostate Cancer
- (2021) Daniel H. Kwon et al. CANCER
- Distinct Response to Platinum-Based Chemotherapy Among Patients With Metastatic Castration-Resistant Prostate Cancer Harboring Alterations in Genes Involved in Homologous Recombination
- (2021) Liancheng Fan et al. JOURNAL OF UROLOGY
- Genomic profiles and clinical outcomes in primary versus secondary metastatic hormone‐sensitive prostate cancer
- (2021) Emily Nizialek et al. PROSTATE
- CRISPR screening identifies CDK12 as a conservative vulnerability of prostate cancer
- (2021) Hanqi Lei et al. Cell Death & Disease
- Pan-cancer Analysis of CDK12 Alterations Identifies a Subset of Prostate Cancers with Distinct Genomic and Clinical Characteristics
- (2020) Bastien Nguyen et al. EUROPEAN UROLOGY
- Low expression of CDK12 in gastric cancer is correlated with advanced stage and poor outcome
- (2020) Meijia Liu et al. PATHOLOGY RESEARCH AND PRACTICE
- Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes
- (2020) Elsa Bernard et al. NATURE MEDICINE
- Characterizing CDK12-Mutated Prostate Cancers
- (2020) Pasquale Rescigno et al. CLINICAL CANCER RESEARCH
- Pan‐Cancer Analysis of CDK12 Loss‐of‐Function Alterations and Their Association with the Focal Tandem‐Duplicator Phenotype
- (2019) Ethan S. Sokol et al. ONCOLOGIST
- CDK 12 drives breast tumor initiation and trastuzumab resistance via WNT and IRS 1‐ErbB‐ PI 3K signaling
- (2019) Hee‐Joo Choi et al. EMBO REPORTS
- Clinical Outcomes in Cyclin-dependent Kinase 12 Mutant Advanced Prostate Cancer
- (2019) Melissa A. Reimers et al. EUROPEAN UROLOGY
- Genomics of lethal prostate cancer at diagnosis and castration resistance
- (2019) Joaquin Mateo et al. JOURNAL OF CLINICAL INVESTIGATION
- Whole-genome sequencing of prostate cancer reveals novel mutation-driven processes and molecular subgroups
- (2019) Caixia Liang et al. LIFE SCIENCES
- Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate Cancer
- (2018) Yi-Mi Wu et al. CELL
- Structural Alterations Driving Castration-Resistant Prostate Cancer Revealed by Linked-Read Genome Sequencing
- (2018) Srinivas R. Viswanathan et al. CELL
- Cyclin-Dependent Kinase 12, Immunity, and Prostate Cancer
- (2018) Emmanuel S. Antonarakis NEW ENGLAND JOURNAL OF MEDICINE
- 793PDPreliminary results from TRITON2: A phase II study of rucaparib in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) associated with homologous recombination repair (HRR) gene alterations
- (2018) W Abida et al. ANNALS OF ONCOLOGY
- Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer
- (2018) David A. Quigley et al. CELL
- Clinical Features and Therapeutic Outcomes in Men with Advanced Prostate Cancer and DNA Mismatch Repair Gene Mutations
- (2018) Emmanuel S. Antonarakis et al. EUROPEAN UROLOGY
- Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial
- (2017) Elizabeth M Swisher et al. LANCET ONCOLOGY
- CDK12 regulates alternative last exon mRNA splicing and promotes breast cancer cell invasion
- (2017) Jerry F. Tien et al. NUCLEIC ACIDS RESEARCH
- Ovarian Cancers Harboring Inactivating Mutations inCDK12Display a Distinct Genomic Instability Pattern Characterized by Large Tandem Duplications
- (2016) Tatiana Popova et al. CANCER RESEARCH
- Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range
- (2016) Dehui Luo et al. STATISTICAL METHODS IN MEDICAL RESEARCH
- Cdk12 is essential for embryonic development and the maintenance of genomic stability
- (2015) H-C Juan et al. CELL DEATH AND DIFFERENTIATION
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) Dung T. Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
- (2015) Joaquin Mateo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ovarian carcinoma CDK12 mutations misregulate expression of DNA repair genes via deficient formation and function of the Cdk12/CycK complex
- (2015) Kingsley M. Ekumi et al. NUCLEIC ACIDS RESEARCH
- Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range
- (2015) Xiang Wan et al. BMC Medical Research Methodology
- Ovarian Cancer-associated Mutations Disable Catalytic Activity of CDK12, a Kinase That Promotes Homologous Recombination Repair and Resistance to Cisplatin and Poly(ADP-ribose) Polymerase Inhibitors
- (2014) Poorval M. Joshi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Genome-wide Profiling of Genetic Synthetic Lethality Identifies CDK12 as a Novel Determinant of PARP1/2 Inhibitor Sensitivity
- (2013) I. Bajrami et al. CANCER RESEARCH
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now